Over the past 12 months, 3 insiders at MYRIAD GENETICS INC filed 5 open-market SEC Form 4 transactions on MYGN: 5 purchases worth $722K and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on May 14, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 26 | Paul Bisaro | BUY | 7.5K | $3.69 | $28K |
| Mar 9, 26 | Samraat S. RahaPresident and CEO | BUY | 40.0K | $5.00 | $200K |
| Feb 27, 26 | S. Louise PhanstielDirector | BUY | 48.0K | $4.66 | $224K |
| Feb 26, 26 | S. Louise PhanstielDirector | BUY | 50.4K | $4.80 | $242K |
| Feb 25, 26 | S. Louise PhanstielDirector | BUY | 6.1K | $4.74 | $29K |
| Oct 11, 24 | Paul J DiazPresident and CEO | SELL | 15.0K | $22.93 | $344K |
| Sep 11, 24 | Paul J DiazPresident and CEO | SELL | 15.0K | $26.72 | $401K |
| Sep 11, 24 | Dale MuzzeyChief Scientific Officer | SELL | 2.1K | $26.17 | $55K |
| Sep 9, 24 | Heinrich DreismannDirector | SELL | 10.0K | $27.05 | $271K |
| Sep 3, 24 | Colleen F ReitanDirector | SELL | 46.0K | $27.95 | $1.3M |
| Aug 21, 24 | Margaret AnconaSVP, Chief of Staff | SELL | 11.5K | $27.82 | $321K |
| Aug 19, 24 | Rashmi KumarDirector | SELL | 7.5K | $28.01 | $210K |
| Jun 4, 24 | Daniel K SpiegelmanDirector | SELL | 3.8K | $22.05 | $84K |
| Jun 3, 24 | Daniel K SpiegelmanDirector | SELL | 3.8K | $22.04 | $83K |
| May 15, 24 | Paul J DiazPresident and CEO | SELL | 75.0K | $25.07 | $1.9M |
| May 14, 24 | Paul J DiazPresident and CEO | SELL | 95.0K | $25.21 | $2.4M |
| May 13, 24 | Paul J DiazPresident and CEO | SELL | 57.8K | $25.13 | $1.5M |
| May 13, 24 | Lee Nisley NewcomerDirector | SELL | 6.2K | $25.30 | $157K |
| Dec 1, 23 | Richard Bryan RiggsbeeChief Financial Officer | SELL | 30.0K | $19.09 | $573K |
| Nov 1, 23 | Richard Bryan RiggsbeeChief Financial Officer | SELL | 30.0K | $15.69 | $471K |
| Jun 2, 23 | Daniel K SpiegelmanDirector | SELL | 8.6K | $23.01 | $199K |
| Mar 27, 23 | Nicole LambertChief Operating Officer | SELL | 6.4K | $23.48 | $151K |
| Mar 2, 23 | Nicole LambertChief Operating Officer | SELL | 13.2K | $22.74 | $300K |
| Mar 2, 23 | Richard Bryan RiggsbeeChief Financial Officer | SELL | 15.0K | $22.55 | $338K |
| Jan 20, 23 | Richard Bryan RiggsbeeChief Financial Officer | SELL | 9.4K | $20.04 | $188K |
| Jan 18, 23 | Richard Bryan RiggsbeeChief Financial Officer | SELL | 600 | $20.01 | $12K |
| Dec 27, 22 | Richard Bryan RiggsbeeChief Financial Officer | SELL | 20.0K | $15.15 | $303K |
| Jun 6, 22 | Daniel K SpiegelmanDirector | SELL | 6.4K | $19.25 | $124K |
| Feb 28, 22 | Jayne B. HartChief People Officer | SELL | 7.0K | $25.00 | $175K |
| Oct 1, 21 | Nicole LambertSee Remarks | SELL | 1.4K | $31.57 | $45K |
| Sep 27, 21 | Nicole LambertSee Remarks | SELL | 10.1K | $33.10 | $335K |
| Sep 23, 21 | Jerry S LanchburyChief Scientific Officer | SELL | 200 | $35.06 | $7K |
| Sep 17, 21 | Jayne B. HartChief People Officer | SELL | 64.5K | $33.72 | $2.2M |
| Aug 27, 21 | Nicole LambertSee Remarks | SELL | 945 | $34.50 | $33K |
| Aug 24, 21 | Jerry S LanchburyChief Scientific Officer | SELL | 30.0K | $35.57 | $1.1M |
| Aug 23, 21 | Jerry S LanchburyChief Scientific Officer | SELL | 40.0K | $35.57 | $1.4M |
| Aug 5, 21 | Jerry S LanchburyChief Scientific Officer | SELL | 28.2K | $35.57 | $1.0M |
| Aug 5, 21 | S. Louise PhanstielDirector | SELL | 47.9K | $35.04 | $1.7M |
| Aug 4, 21 | Jerry S LanchburyChief Scientific Officer | SELL | 38.2K | $35.57 | $1.3M |
| Aug 3, 21 | Jerry S LanchburyChief Scientific Officer | SELL | 27.8K | $35.07 | $946K |
| Aug 3, 21 | Dennis LangerDirector | SELL | 30.0K | $34.75 | $1.0M |
| Aug 3, 21 | Richard Bryan RiggsbeeChief Financial Officer | SELL | 15.0K | $35.14 | $527K |
Over the past 12 months, insiders at MYRIAD GENETICS INC filed 5 open-market purchases worth $722K and 0 sales worth $0 on MYGN, which makes them net buyers over the period. The most recent Form 4 was filed on May 14, 26.
The largest recent open-market MYGN insider purchase in our data was $242K by S. Louise Phanstiel, Director, filed on Feb 26, 26.
3 different insiders at MYRIAD GENETICS INC filed open-market SEC Form 4 transactions on MYGN over the last 12 months.
InsiderTape plots every MYGN insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every MYRIAD GENETICS INC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →